ERFSF (Eurofins Scientific SE) Days Sales Outstanding: 54.98 (As of Jun. 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ERFSF Eurofins Scientific SE ERFSF
79 GF Score
Price $81.61
GF Value $75.70
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Eurofins Scientific SE Days Sales Outstanding?

Eurofins Scientific SE ERFSF +2.64% 79 Days Sales Outstanding is 54.98 as of Jun. 2026, which is 7% below its 10-year median of 59.30. GuruFocus rates ERFSF with a GF Score™ of 79/100 and a GF Value™ of $75.70 (Fairly Valued). The stock has 6 warning signs investors should review. Among 201 Medical Diagnostics & Research companies, Eurofins Scientific SE ranks better than 65.17% on this metric.

Eurofins Scientific SE's average Accounts Receivable for the six months ended in Jun. 2026 was $1,285 Mil. Eurofins Scientific SE's Revenue for the six months ended in Jun. 2026 was $4,264 Mil. Hence, Eurofins Scientific SE's Days Sales Outstanding for the six months ended in Jun. 2026 was 54.98.

The historical rank and industry rank for Eurofins Scientific SE's Days Sales Outstanding or its related term are showing as below:

ERFSF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 54.06   Med: 59.3   Max: 71.54
Current: 54.06

During the past 13 years, Eurofins Scientific SE's highest Days Sales Outstanding was 71.54. The lowest was 54.06. And the median was 59.30.

ERFSF's Days Sales Outstanding is ranked better than
65.17% of 201 companies
in the Medical Diagnostics & Research industry
Industry Median: 67.73 vs ERFSF: 54.06

Eurofins Scientific SE's Days Sales Outstanding increased from Jun. 2025 (52.12) to Jun. 2026 (54.98).


Eurofins Scientific SE  (OTCPK:ERFSF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Eurofins Scientific SE Days Sales Outstanding Related Terms


Eurofins Scientific SE Days Sales Outstanding Historical Data

* Premium members only.

The historical data trend for Eurofins Scientific SE's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eurofins Scientific SE Days Sales Outstanding Chart

Eurofins Scientific SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 56.32 59.14 58.72 58.07 51.92

Eurofins Scientific SE Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 57.94 57.06 52.12 53.26 54.98

ERFSF vs TMO, DHR, IDXX: Days Sales Outstanding Comparison

For the Diagnostics & Research subindustry, Eurofins Scientific SE's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eurofins Scientific SE Days Sales Outstanding vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Eurofins Scientific SE's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Eurofins Scientific SE's Days Sales Outstanding falls into.


ERFSF
79GF Score
Eurofins Scientific SE ERFSF
Days Sales Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eurofins Scientific SE Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Eurofins Scientific SE's Days Sales Outstanding for the fiscal year that ended in Dec. 2025 is calculated as

Days Sales Outstanding (A: Dec. 2025 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2024 ) + Accounts Receivable (A: Dec. 2025 )) / count ) / Revenue (A: Dec. 2025 )*Days in Period
=( (1145.969 + 1284.426) / 2 ) / 8543.443*365
=1215.1975 / 8543.443*365
=51.92

Eurofins Scientific SE's Days Sales Outstanding for the quarter that ended in Jun. 2026 is calculated as:

Days Sales Outstanding (Q: Jun. 2026 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2025 ) + Accounts Receivable (A: Jun. 2026 )) / count ) / Revenue (A: Jun. 2026 )*Days in Period
=( (1284.426 + 1284.908) / 2 ) / 4264.286*365 / 2
=1284.667 / 4264.286*365 / 2
=54.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Sales Outstanding →
What does a Days Sales Outstanding of 54.98 mean?
Eurofins Scientific SE (ERFSF) has a Days Sales Outstanding of 54.98 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Eurofins Scientific SE and its competitors. This is near median its historical median of 59.30. Over the past decade, Eurofins Scientific SE's Days Sales Outstanding has ranged from 54.06 to 71.54. According to the industry distribution chart, Eurofins Scientific SE ranks #70 out of 201 companies in the Medical Diagnostics & Research industry, placing it in the top 34.8%.
Is Eurofins Scientific SE's Days Sales Outstanding too high?
Eurofins Scientific SE's current Days Sales Outstanding of 54.98 is near median its 10-year median of 59.30. Over the past 10 years, this metric has ranged from a low of 54.06 to a high of 71.54. The Medical Diagnostics & Research industry median Days Sales Outstanding is 67.73. Eurofins Scientific SE's value of 54.98 is 18.8% below this industry median. Based on the distribution chart, Eurofins Scientific SE ranks #70 out of 201 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Eurofins Scientific SE has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Eurofins Scientific SE's Days Sales Outstanding compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Eurofins Scientific SE ranks #70 out of 201 companies for Days Sales Outstanding. This puts Eurofins Scientific SE in the upper half of its industry. The industry median Days Sales Outstanding is 67.73. Eurofins Scientific SE's value of 54.98 is 18.8% below this benchmark. Historically, Eurofins Scientific SE's own Days Sales Outstanding has ranged from 54.06 to 71.54 over the past decade. While the company's 10-year median is 59.30 vs. the industry median of 67.73, Eurofins Scientific SE has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Medical Diagnostics & Research company?
The median Days Sales Outstanding among Medical Diagnostics & Research companies is 67.73, based on 201 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eurofins Scientific SE's current Days Sales Outstanding of 54.98 is 18.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Eurofins Scientific SE and its competitors. For the Medical Diagnostics & Research industry, the median Days Sales Outstanding is 67.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eurofins Scientific SE's current Days Sales Outstanding is 54.98, which is near median its own 10-year median of 59.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eurofins Scientific SE stock overvalued right now?
Based on GuruFocus' analysis, Eurofins Scientific SE (ERFSF) is currently considered Fairly Valued. The stock's GF Value™ is $75.70, compared to a current price of $81.61 — trading 7.8% above its estimated fair value. The current Days Sales Outstanding is 54.98, which is near median its 10-year median of 59.30 and 18.8% below the Medical Diagnostics & Research industry median of 67.73. Eurofins Scientific SE's overall GF Score™ is 79/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Eurofins Scientific SE (ERFSF), the current Days Sales Outstanding is 54.98 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eurofins Scientific SE (ERFSF) Overvalued in 2026?

Based on GuruFocus' analysis, Eurofins Scientific SE stock appears to be overvalued. The current stock price of $81.61 is trading 7.8% above its estimated GF Value™ of $75.70. GuruFocus considers Eurofins Scientific SE to be Fairly Valued.

Key valuation signals for ERFSF:

  • Days Sales Outstanding: 54.98 (near median its 10-year median of 59.30)
  • GF Value™: $75.70 vs. price of $81.61 (7.8% above fair value)
  • GF Score™: 79/100 with 6 warning signs
  • Industry Position: 18.8% below the Medical Diagnostics & Research median (#70 of 201)

No single metric tells the full story. See the ERFSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Eurofins Scientific SE Business Description

Address 23 Val Fleuri, Luxembourg, LUX, 1526
Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 950 laboratories in 61 countries. Its revenue from Europe, North America, and the rest of the world contributes approximately 50%, 40%, and 10% of total revenue, respectively. Its areas of business activity are food, feed, and environmental testing ("life"), biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.
79GF Score

Get the complete analysis for ERFSF

Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$81.61
Price
$75.70
GF Value